Literature DB >> 23426328

Long-term prognosis in community-acquired pneumonia.

Marcos I Restrepo1, Paola Faverio, Antonio Anzueto.   

Abstract

PURPOSE OF REVIEW: Pneumonia is considered the leading infectious diseases cause of death and the seventh leading cause of death overall in the US. There is significant interest in understanding the relationship between community-acquired pneumonia (CAP) and mortality. RECENT
FINDINGS: Most clinical studies examining patients with CAP have used an arbitrary in-hospital or 30-day mortality as a short-term mortality clinical end point. However, long-term mortality (arbitrary >3 months) factors, incidence, prediction, and implications on patient care are important issues that require further evaluation in patients with CAP. This review focuses on the most recent literature assessing the importance and the frequency of long-term associated outcomes in patients with CAP, the risk factors, and possible implications for future strategies. Multiple risk factors that include age, sex, comorbid conditions, type of pneumonia, and severity of illness are associated with higher long-term mortality. In addition, several biomarkers were demonstrated to be independently associated with long-term mortality.
SUMMARY: Despite advances in the understanding of long-term mortality among CAP patients, there is still a high unacceptable long-term mortality. Public health programs should address this important gap, considering the high level of complexity factors in patients with CAP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426328      PMCID: PMC4066634          DOI: 10.1097/QCO.0b013e32835ebc6d

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  84 in total

1.  Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.

Authors:  Stefan Krüger; Santiago Ewig; Jan Kunde; Oliver Hartmann; Norbert Suttorp; Tobias Welte
Journal:  Thorax       Date:  2010-03       Impact factor: 9.139

Review 2.  Severe community-acquired pneumonia.

Authors:  Marcos I Restrepo; Antonio Anzueto
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

Review 3.  Role of acute infection in triggering acute coronary syndromes.

Authors:  Vicente F Corrales-Medina; Mohammad Madjid; Daniel M Musher
Journal:  Lancet Infect Dis       Date:  2010-02       Impact factor: 25.071

4.  Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia.

Authors:  Bertrand Renaud; Aline Santin; Eva Coma; Nicolas Camus; Dave Van Pelt; Jan Hayon; Merce Gurgui; Eric Roupie; Jérôme Hervé; Michael J Fine; Christian Brun-Buisson; José Labarère
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

5.  Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia.

Authors:  Laura M Cecere; Gordon D Rubenfeld; David R Park; Richard K Root; Christopher H Goss
Journal:  Respiration       Date:  2009-11-04       Impact factor: 3.580

6.  Community-acquired methicillin-resistant Staphylococcus aureus pneumonia and ARDS: 1-year follow-up.

Authors:  Lena M Napolitano; Melissa E Brunsvold; Raju C Reddy; Robert C Hyzy
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

7.  Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Robert Thomann; Claudine Falconnier; Marcel Wolbers; Isabelle Widmer; Stefanie Neidert; Thomas Fricker; Claudine Blum; Ursula Schild; Katharina Regez; Ronald Schoenenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Mueller
Journal:  JAMA       Date:  2009-09-09       Impact factor: 56.272

8.  Pneumonia mortality in a UK general practice population cohort.

Authors:  Puja R Myles; Richard B Hubbard; Jack E Gibson; Zara Pogson; Christopher J P Smith; Tricia M McKeever
Journal:  Eur J Public Health       Date:  2009-06-23       Impact factor: 3.367

9.  Diagnosis of pulmonary malignancy after hospitalization for pneumonia.

Authors:  Eric M Mortensen; Laurel A Copeland; Mary Jo Pugh; Michael J Fine; Brandy Nakashima; Marcos I Restrepo; Rosa Malo de Molina; Antonio Anzueto
Journal:  Am J Med       Date:  2010-01       Impact factor: 4.965

10.  New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.

Authors:  S Ewig; N Birkner; R Strauss; E Schaefer; J Pauletzki; H Bischoff; P Schraeder; T Welte; G Hoeffken
Journal:  Thorax       Date:  2009-05-18       Impact factor: 9.139

View more
  40 in total

1.  Is Pneumonia a Risk Factor or a Risk Marker for Long-Term Mortality?

Authors:  Carlos G Grijalva
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

2.  Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons.

Authors:  Núria Torner; Conchita Izquierdo; Núria Soldevila; Diana Toledo; Judith Chamorro; Elena Espejo; Amelia Fernández-Sierra; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

Review 3.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

4.  The genetic architecture of pneumonia susceptibility implicates mucin biology and a relationship with psychiatric illness.

Authors:  William R Reay; Michael P Geaghan; Murray J Cairns
Journal:  Nat Commun       Date:  2022-06-29       Impact factor: 17.694

5.  Long-Term Cognitive Impairment after Hospitalization for Community-Acquired Pneumonia: a Prospective Cohort Study.

Authors:  Timothy D Girard; Wesley H Self; Kathryn M Edwards; Carlos G Grijalva; Yuwei Zhu; Derek J Williams; Seema Jain; James C Jackson
Journal:  J Gen Intern Med       Date:  2018-01-26       Impact factor: 5.128

Review 6.  The management of community-acquired pneumonia in the elderly.

Authors:  Paola Faverio; Stefano Aliberti; Giuseppe Bellelli; Giulia Suigo; Sara Lonni; Alberto Pesci; Marcos I Restrepo
Journal:  Eur J Intern Med       Date:  2013-12-17       Impact factor: 4.487

7.  Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study.

Authors:  Mohammed Yousufuddin; Umesh M Sharma; Sumit Bhagra; Mohammad Hassan Murad
Journal:  BMJ Open Respir Res       Date:  2021-03

8.  An unusual cause of fungal pneumonia.

Authors:  S Dharmic; Shraddha Nair; M Harish
Journal:  J Pharm Bioallied Sci       Date:  2015-04

9.  Population-based incidence and mortality of community-acquired pneumonia in Germany.

Authors:  Christian Theilacker; Ralf Sprenger; Friedhelm Leverkus; Jochen Walker; Dennis Häckl; Christof von Eiff; Julia Schiffner-Rohe
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

10.  Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data.

Authors:  Steven B Smith; Michal Magid-Slav; James R Brown
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.